Download cancer-research

WHAT IS TRANSFER FACTOR?
“THE MOST POWERFULL
IMMUNE SYSTEM SUPPORT
AVAILABLE TODAY”
and
the safest too…..
WHAT IS THE DIFFERENCE BETWEEN TF PLUS
AND TF ADVANCE FORMULA ?



TF Plus and Advance Formula are different and must
be applied differently depending on the condition of
the patient.
TF Plus is proven to be effective for numerous
degenerative diseases and especially for growths in
the body such as Cysts, Fibroids, Fibrodenomas,
Cancers, etc.
TF Advance Formula is applied to people with
autoimmune diseases because it can balance and
modulate the immune system
TF Plus boost NK cell
activity 400+% and
TF Advance Formula
283% above the
normal immune
response
TF Advance Formula
TF Plus
LIST OF AUTOIMMUNE DISEASES
Neuromuscular system
Myasthenia gravis
Emos-Lumbert myasthenic syndrome
Stiff man syndrome
Acute disseminated encephalomyelitis
Multiple Sclerosis
Gullain-Barre syndrome
Chronic inflammatory demyelinating
Polyradiculoneuropathy
Multifocal motor neuropathy with
Conduction block
Chronic neuropathy with monoclonal
Gammopathy
Paraneoplastic neurologic disorders
Opsoclonus-myoclonujs syndrome
Cerebellar degneration
Encephalomyelitis
Rectimopathy
Hepatobiliary system:
Autoimmune chronic active
hepatitis
Primary biliary sclerosis
Sclerosing cholangitis
Gastrointestinal tract
Gluten-sensitive enteropathy
Pernicious anemia
Inflammatory bowel disease
Skin


















Pemphigus vulgaris
Pemphigus follaceus
Paraneoplastic pemphigus
Bullus pemphigoid
Dermatitis herpetiformis
Linear LgA disease
Spidermolysis bullosa acquisita
Autoimmune alopecia
Erythera nodosa
Pemphigoid gestaionis
Cicatncial pemphigoid
Chronic bullous disease of
childhood
Hematologic system:
Autoimmune hemolytic anemia
Autoimmune thrombocytopenic
purpura
Idiopathic
Drug related
Autoimmune neutropenia
Endocrine System









Thyroid Gland
Hashimoto's thyroiditis
Graves' Disease
Thyroiditis with hyperthyroidism
Type I autoimmune polyglandular
syndrome
Type II autoimmune
polyglandular syndrome
Insulin-dependent diabetes
mellitus
Immune-mediated infertility
Autoimmune Addison's disease
Connective tissue diseases













Systemic lupus erythematosus
Rheumatoid arthritis
Systemic sclerosis
(scleroderma)
Anklosing spondylitis
Reactive ardrides
Polymyositis/dermatomyositis
Sjogren's syndrome
Mixed connective tissue
disease
Bebcet's syndrome
Psoriasis
Vasculitic syndromes:
Systemic necrotizing
vascolitides
Classic polyarteritis nodosa













Allergic angitis &
granuloratosa
(Chorg-Strauss Disease)
Hypersensitivity vasolitis
Wengener's granulomatosis
Temporal arteritis
Taksyasa's arteritis
Kawasaki's disease
Isolated vasculitis of the
Central nervous system
Thromboangitis obliterans
Miscellaneous Vasculitides
Sarcoidosis
Graft-versus-host disease
Cryopathies
LIST OF TYPES OF CANCERS


















Anal
Bile duct
Bladder
Bone
Bone, secondary
Bowel (colon &
rectum)
Brain
Brain, secondary
Breast
Breast, secondary
Carcinoid
Cervix
Children's cancers
Endocrine
Eye
Gall bladder
Gullet (oesophagus)
Head & neck
Kaposi's sarcoma
Kidney
Larynx
Leukaemia
Leukaemia, acute lymphoblastic
Leukaemia, acute myeloid
Leukaemia, chronic lymphocytic
Leukaemia, chronic myeloid
Liver
Liver, secondary
Lung
Lung, secondary
Lymph nodes, secondary
Lymphoma, Hodgkin's
Lymphoma, non-Hodgkin's
Melanoma
Mesothelioma
Myeloma
Soft tissue sarcomas
Neuroendocrine
Ovary
Pancreas
Penis
Prostate
Skin
Spinal cord
Stomach
Testes
Thyroid
Unknown primary
Vagina
Vulva
Womb (uterus)
BLADDER CANCER

Bladder cancer affects
twice as many men as
women in the UK. It is
the fourth most common
cancer in men and the
tenth most common in
women. Each year, there
are over 10,600 new
cases.
Bladder cancer is most
common in people over
50. It affects the inner
lining of the bladder and
develops slowly. As it
grows, it may spread to
other organs near the
bladder
BONE CANCER

Cancers that start in the
bone are rare. There are
around 500 new cases in
the UK each year. They are
different from cancers that
develop at other sites in the
body and spread to the
bones later on.
Bone cancer develops from
cells in the bone. A rarer
type can start in cartilage,
the firm connective tissue
that surrounds and
cushions many joints. If the
cancer is not treated,
cancer cells from the
original site may break
away and spread to other
parts of the body, such as
the lungs, other bones, or
other internal organs.

BREAST CANCER
Breast cancer is the most
common cancer for women in
this country. Each year, there
are over 41,000 new cases in
the UK. This cancer accounts
for almost one in three of all
cancer cases in women, and
the lifetime risk for breast
cancer in women is one in
nine.
The cancer develops in the
milk-producing glands in the
breast, or in the passages or
ducts that deliver milk to the
nipples. Some breast cancers
may spread into the
surrounding tissue, and can
spread to other parts of the
body.

BRAIN TUMORS
Brain tumours are not very
common, and unlike many
other cancers, does not
usually spread to other parts
of the body. It accounts for
less than 2% of all new
cancers diagnosed in the UK.
Each year, there are over
2,500 new cases of brain
cancer in men, and over
1,900 cases in women. In the
UK, about 300 children are
diagnosed with a brain
tumour each year.
The brain is a soft spongy
mass of nerve cells and
supporting tissue. It controls
every physiological system in
the body and is responsible
for our thoughts, language
and emotions.
In the brain, any abnormal
growth puts pressure on
sensitive structures and may
impair their function.

MULTIPLE MYELOMA
Myeloma develops from cells
within the bone marrow called
plasma cells. Plasma cells
produce proteins called
antibodies, which help to fight
infection. In myeloma, a single
plasma cell develops faults
and multiplies out of control.
This makes the immune
system much less effective at
fighting infection.
Myeloma cells produce
excessive amounts of a single
type of antibody, which is
known as paraprotein, or
monoclonal spike.
Myeloma usually develops at a
number of different sites
within the body. This cancer is
therefore called multiple
myeloma. The most common
sites for multiple myeloma are
the pelvis, spine, rib cage,
skull, shoulders and hips.

CERVICAL CANCER
Cervical cancer develops from
cells lining the cervix, which is
the canal that connects the
uterus to the vagina. During
childbirth, the baby passes
through this canal.
Cervical cancer takes time to
develop. There is usually a
period when some of the cells
lining the cervix develop
abnormal changes but are not
yet cancerous - these can give
rise to cervical cancer later on.
Doctors can pick up these
changes through screening,
and a simple treatment can
prevent cancer developing.
HODGKIN’S LYMPHOMA

Hodgkin's lymphoma is a fairly rare type of cancer, with just over
1,400 new cases in the UK every year. It is most common in
people in their 20s and 30s.
This disease belongs to a group of cancers known as lymphomas.
Lymphomas are cancers that develop from cells of the lymphatic
system. This system helps to protect the body against infections.
There are two main types of lymphoma, Hodgkin's lymphoma and
non-Hodgkin's lymphoma.
Hodgkin's lymphoma is named after Thomas Hodgkin, the doctor
who first described it. It makes up less than one in five cases of
lymphoma. The cancer cells in Hodgkin's lymphoma look different
under a microscope from cells of non-Hodgkin's lymphoma.
In the majority of cases, Hodgkin's lymphoma can be cured with
modern treatments, particularly if the disease is in its early stages.
If the cancer is not treated, cancer cells may break away and
spread to other parts of the lymphatic system. If the cancer cells
get into the blood stream, they can spread to almost any organ in
the body, including the liver, lungs, brain and spine.

MELANOMA
There are two main types of skin
cancer, melanoma and nonmelanoma skin cancer.
Melanoma is the most serious
form of skin cancer.
Melanoma (also known as
malignant melanoma) is a cancer
that develops from cells called
melanocytes, which are found in
the outer layer of our skin.
Melanocytes produce melanin, a
pigment that helps protect the
deeper layers of our skin from
the harmful effects of the sun.
This pigment appears as a
suntan, which is a sign of
damaged skin.
Melanomas often start in moles,
but they can also develop
elsewhere on the skin. In rare
cases, melanomas can occur in
the eye, under the fingernails, or
in other parts of the body not
usually exposed to the sun

KARPOSI’S SARCOMA
Although Kaposi's sarcoma
(KS) is a type of cancer it
differs from other types of
cancer in the way it develops.
Unlike most cancers, which
start in one place and may
then spread around the body,
KS can appear in several
parts of the body at the same
time. The most common site
for KS is on the skin but it
may also affect internal
organs, particularly the lymph
nodes, the lungs and parts of
the digestive system.
KS has been shown to be
associated with a virus called
Human Herpes Virus 8
(HHV8) and can affect
people with a weakened
immune system, including
people with HIV (Human
Immunodeficiency Virus) and
AIDS.
SOFT TISSUE SARCOMA’S

Soft tissue sarcomas are rare, and only 1,300 or so
people a year in the UK will develop a sarcoma.
Sarcomas are cancers that develop from cells in the
soft, supporting tissues of the body. They can occur
in muscle, fat, blood vessels or in any of the other
tissues that support, surround and protect the organs
of the body. The soft tissues of the body are also
known as the mesenchyma, and so sometimes
sarcomas are called mesenchymal tumours. Some
types of sarcoma occur in children, teenagers and
young adults, but generally sarcomas are more likely
to develop in people over the age of 30.
Some sarcomas, such as osteosarcoma, start in bone.
These grow and develop differently and are treated
differently from soft tissue sarcomas.
Neuroendocrine tumours

Neuroendocrine tumours are rare. They start in
neuroendocrine cells - these are specialised nerve cells that
produce hormones. Neuroendocrine cells are part of the
endocrine system, which is a network of glands in the body.
The glands produce hormones.
Hormones control many of the body’s functions by
controlling the levels of particular chemicals and fluids in
the body, and they help us respond to changes in our
environment.
Neuroendocrine tumours occur most commonly in the
digestive system but can occur in other parts of the body.
They can be non-cancerous (benign) or cancerous
(malignant).
Some neuroendocrine tumours produce hormones which
can cause particular symptoms, such as diarrhoea, flushing
of the skin and wheezing. Tumours that produce hormones
are called functioning (hormone-secreting). Tumours that
don't produce hormones are known as non-functioning
(non-hormone secreting).
Mesothelioma

Mesothelioma (pronounced mee-so-thee-lee-oma) is a cancer of
the mesothelium. The mesothelium is a thin membrane that
lines the chest and abdomen and surrounds the organs in these
areas. The lining around the lungs is called the pleura and in
the abdomen it is known as the peritoneum.
Mesotheliomas are uncommon cancers, although they are
becoming more frequent. Currently, about 1800 people in the
UK are diagnosed with mesothelioma each year.
Mesothelioma of the lining of the lungs (pleural
mesothelioma) is much more common than mesothelioma in
the peritoneum. For every person with peritoneal mesothelioma
there will be about 12 people who have pleural mesothelioma.
Cancers of the bile duct

Cancers of the bile duct are rare in the Western world. There
are approximately 600 new cholangiocarcinomas diagnosed
each year in the UK.
The bile ducts are the tubes connecting the liver and gall
bladder to the small intestine (small bowel). Bile is a fluid
made by the liver and stored in the gall bladder. Its main
function is to break down fats during their digestion in the
small intestine. In people who have had their gall bladder
removed, bile flows directly into the small intestine. The bile
ducts and gall bladder are known as the biliary system.
Cancer is classified according to the type of cell from which it
starts. Cancer of the biliary system almost always starts in a
type of tissue called glandular tissue and is then known as
adenocarcinoma.
If the cancer starts in the part of the bile ducts contained
within the liver it is known as intra-hepatic. If it starts in the
area of the bile ducts outside the liver it is known as extrahepatic.
Nose Cancer (Nasopharyngeal Cancer)

The nasopharynx is the
area where the back of
the nose turns to meet
the upper section of the
throat. The cancerous
tumour usually originates
at the curved part behind
the nose or the post nasal
space. As the tumour is
situated close to critical
structures of the brain,
spinal cord and throat,
nasopharyngeal cancer
can cause many
symptoms in its advanced
stages.

It is common among the Chinese population, particularly in
Hong Kong and Southern China. In Malaysia, we are talking
about an incidence of 25 cases for every 100,000 people in the
population.
According to the recent National Cancer Registry,
nasopharyngeal cancer is the second most common cancer in
Malaysian men, after lung cancer. In comparison to the rest of
the world, the Malaysian Chinese male has the second highest
incidence; the local Chinese women have the highest incidence
in the world.
The incidence rises with age, particularly between the ages of
50 and 60. But as our population expands, we are definitely
seeing more cases in recent years.
An epidemiology study in Hong Kong many years ago found an
association between eating salted fish at a young age and the
occurrence of nasal cancer. However, recent studies have
implicated viral origin of the disease. He virus implicated is
known as the Epstein-Barr virus. While many of us have that
virus sitting dormantly behind our noses, some of us will
eventually develop cancer due to the complex interaction of the
virus and our genes. Other environmental factors include the
consumption of preserved food and fermented fish products, as
well as exposure to toxic fumes and tobacco.
Symptoms
Early symptoms include:
· bleeding nose
· hearing problems, such as ringing and tingling
· blocked nose
As the disease progresses, symptoms may include:
· hearing loss
· numbness in the face
· coughing out blood
· swallowing problems
· breathing difficulties caused by a blocked nose
· double vision

Diagnosis:
The first stage of diagnosis involves a full ENT (ear, nose and
throat) examination by a specialist, which includes examining
the back part of the nose. If a swelling or bulge is present, a
biopsy is indicated. A biopsy involves removing a small piece of
tissue sample to determine the presence of cancer cell. It is
essential in making a diagnosis.
The ENT specialist is usually the first port of call for patients, as
most of them think of their symptoms as common ENT
problems. As soon as the ENT specialist detects something
amiss or the biopsy is confirmed for cancer, the patient will be
referred to an oncologist. The role of the clinical oncologist is to
treat the cancer with radiotherapy or chemotherapy, or both.
More tests will be done to determine the extent of disease and
the best way to treat the patient. This includes a computed
tomography (CT) scan or magnetic resonance imaging (MRI) of
the head and neck area. X-ray or scans of the chest, liver and
bone are also necessary to find out if the cancer has spread to
those areas.

Treatment:
At Stage I or II of the disease, where the tumour is confined to
the back of the nose, the treatment choice is radiotherapy.
Radiotherapy is an X-ray treatment using high-energy radiation
to kill cancer cells. Radiation is given to the tumour site, which
will also include the neck and throat. It is given daily from
Mondays to Fridays for 7 weeks. At these early stages,
treatment can achieve a cure rate of over 90% and recurrence
is very unlikely if an experienced oncologist administers it.
At Stages III and IV, when the lymph nodes have become
infected with tumour (but the tumour has not progressed to
other parts of the body), treatment is a combination of
radiotherapy and chemotherapy. When both treatments are
done concurrently, a cure of between 60% to 70% can be
achieved compared to radiotherapy alone. The side effects are
greater with combination treatment, but this is offset by higher
cure rates.

Side Effects:
Short-term complications start with dry mouth and loss of
taste. This could lead to loss of appetite. By the 3rd and 4th
week of treatment, there will also be difficulty in swallowing,
which will persist throughout treatment. There may be some
skin changes in the treated area. Fortunately, these side effects
are only temporary and will last until treatment is completed.
The taste capacity takes about 2 months to recover, while the
dry mouth never fully recovers, but it’s a small price to pay for
cure.
However, newer treatment techniques using CT scan-based
treatment planning may help reduce these long-term side
effects.
By Dr Ibrahim Wahid

LEUKEMIA
Leukemia is cancer of the white blood cells. The bone
marrow produces abnormal white blood cells that do not
function properly and eventually crowd out normal
white blood cells, red blood cells (erythrocytes), and
platelets.
There are four major types of leukemia, depending on
the type of white blood cell affected and the speed of
progression. Blood cells in the bone marrow form from
two major groups of stem cells: the myeloid stem cell
line and the lymphoid stem cell line. Myeloid stem cells
develop into red blood cells, platelets, and certain kinds
of white blood cells (granulocytes or monocytes). The
lymphoid stem cell line develops into a kind of white
blood cell called lymphocytes. Both stem cell lines can
be affected by leukemia, and both occur in both acute
and chronic forms. Acute leukemia progresses rapidly;
chronic more slowly.
The four types are:




Acute lymphoblastic leukemia (ALL) is the most
common form of leukemia in children, but it can also
affect adults.
Acute myelogenous leukemia (AML) is the most
common form of leukemia and can affect both
children and adults.
Chronic lymphocytic leukemia (CLL) primarily affects
people older than 55 years of age, and rarely affects
children.
Chronic myelogenous leukemia (CML) affects
primarily adults. Unlike CLL, CML eventually but
invariably converts to the more rapidly progressing
acute form if untreated.

Causes of Leukemia
The exact cause of most types of leukemia is
unknown. Many patients do not exhibit any of the
known risk factors, which include smoking and other
tobacco use, exposure to high doses of radiation or
the chemicals benzene or formaldehyde, and
chemotherapy used to treat other cancers. Leukemia
is not an inherited disease, but there may be a
genetic link. Depending on the type of leukemia,
close relatives of a person with leukemia may be up
to four times as likely to develop leukemia as a
person with no affected relatives. Down syndrome
and certain types of blood disorders also increase
the risk of developing the disease.

Symptoms and Diagnosis of Leukemia
As affected cells increase, they begin to crowd out normal cells
and disable them, causing symptoms such as frequent
infections, poor healing of small cuts or sores, and anemia.
The leukemia cells may also collect in certain parts of the
body, causing pain and swelling. Other common symptoms
include: fevers and night sweats, weakness and fatigue,
headaches, bruising of the skin and bleeding from the gums or
rectum, joint pain, swelling in the abdomen from an enlarged
spleen, swollen lymph nodes in the armpit, neck, or groin, and
decreased appetite or weight loss.
If you or a relative has leukemia symptoms, a personal and
family medical history will be taken, and a blood sample sent
to the lab for testing. If your blood tests are abnormal, a test
of bone marrow cells will be taken to confirm the diagnosis. A
spinal tap (lumbar puncture) may also be ordered to
determine whether leukemia cells are present in the brain or
cerebrospinal fluid.

Treatment of Leukemia
Treatment depends on the type of leukemia and the
stage of progression, but commonly includes one or
more bone marrow transplants, radiation, and
chemotherapy. Our understanding and ability to
treat leukemia has come a long way in recent
decades. In 1960, the 5-year survival rate for all
types of leukemia was about 14%. Now it is about
50%. The highest survival rates occur in children
suffering from ALL.
Methods of Treatment
Most patients with leukemia are treated with chemotherapy. Some
also may have radiation therapy and/or bone marrow
transplantation (BMT) or biological therapy. In some cases,
surgery to remove the spleen (an operation called a splenectomy)
may be part of the treatment plan.
- Chemotherapy is the use of drugs to kill cancer cells. Depending
on the type of leukemia, patients may receive a single drug or a
combination of two or more drugs. Some anticancer drugs can be
taken by mouth. Most are given by intravenous injection (injected
into a vein). Often, patients who need to have many IV treatments
receive the drugs through a catheter.
- One end of this thin, flexible tube is placed in a large vein, often in
the upper chest. Drugs are injected into the catheter, rather than
directly into a vein, to avoid the discomfort of repeated injections
and injury to the skin.
- Anticancer drugs given by IV injection or taken by mouth enter the
bloodstream and affect leukemia cells in most parts of the body.
However, the drugs often do not reach cells in the central nervous
system because they are stopped by the blood-brain barrier. This
protective barrier is formed by a network of blood vessels that
filter blood going to the brain and spinal cord. To reach leukemia
cells in the central nervous system, doctors use intrathecal
chemotherapy. In this type of treatment, anticancer drugs are
injected directly into the cerebrospinal fluid.


Intrathecal chemotherapy can be given in two ways. Some
patients receive the drugs by injection into the lower part
of the spinal column. Others, especially children, receive
intrathecal chemotherapy through a special type of catheter
called an Ommaya reservoir. This device is placed under the
scalp, where it provides a pathway to the cerebrospinal
fluid. Injecting anticancer drugs into the reservoir instead
of into the spinal column can make intrathecal
chemotherapy easier and more comfortable for the patient.
Chemotherapy is given in cycles: a treatment period
followed by a recovery period, then another treatment
period, and so on. In some cases, the patient has
chemotherapy as an outpatient at the hospital, at the
doctor's office, or at home. However, depending on which
drugs are given and the patient's general health, a hospital
stay may be necessary.

Radiation therapy is used along with chemotherapy
for some kinds of leukemia. Radiation therapy (also
called Radiotherapy) uses high-energy rays to
damage cancer cells and stop them from growing.
The radiation comes from a large machine.
Radiation therapy for leukemia may be given in two
ways. For some patients, the doctor may direct the
radiation to one specific area of the body where
there is a collection of leukemia cells, such as the
spleen or testicles. Other patients may receive
radiation that is directed to the whole body. This
type of radiation therapy, called total-body
irradiation, usually is given before a bone marrow
transplant.

The term leukemia refers to cancers of the white blood cells,
which are also referred to as leukocytes or WBCs. When a
child has leukemia, large numbers of abnormal white blood
cells are produced in the bone marrow. These abnormal white
cells crowd the bone marrow and flood the bloodstream, but
they cannot perform their proper role of protecting the body
against disease because they are defective.
As leukemia progresses, the cancer interferes with the body's
production of other types of blood cells, including red blood
cells and platelets. This results in anemia (low numbers of red
cells) and bleeding problems, in addition to the increased risk
of infection caused by white cell abnormalities.
As a group, leukemias account for about 25% of all childhood
cancers and affect about 2,200 American young people each
year. Luckily, the chances for a cure are very good with
leukemia. With treatment, most children with leukemia are free
of the disease without it coming back.
Types of Childhood Leukemia



In general, leukemias are classified into acute
(rapidly developing) and chronic (slowly
developing) forms. In children, about 98% of
leukemias are acute.
Acute childhood leukemias are also divided into
acute lymphocytic leukemia (ALL) and acute
myelogenous leukemia (AML), depending on
whether specific white blood cells called
lymphyocytes, which are linked to immune
defenses, are involved.
Approximately 60% of children with leukemia have
ALL, and about 38% have AML. Although slowgrowing chronic myelogenous leukemia (CML)
may also be seen in children, it is very rare,
accounting for fewer than 50 cases of childhood
leukemia each year in the United States.

Risk for Childhood Leukemia
The ALL form of the disease most commonly occurs in younger
children ages 2 to 8, with a peak incidence at age 4. But it can
affect all age groups.
- Children have a 20% to 25% chance of developing ALL or AML
if they have an identical twin who was diagnosed with the
illness before age 6. In general, nonidentical twins and other
siblings of children with leukemia have two to four times the
average risk of developing this illness.
- Children who have inherited certain genetic problems - such as
Li-Fraumeni syndrome, Down syndrome, Kleinfelter syndrome,
neurofibromatosis, ataxia telangectasia, or Fanconi's anemia have a higher risk of developing leukemia, as do children who
are receiving medical drugs to suppress their immune systems
after organ transplants.
- Children who have received prior radiation or chemotherapy for
other types of cancer also have a higher risk for leukemia,
usually within the first 8 years after treatment.


In most cases, neither parents nor children have control
over the factors that trigger leukemia, although current
studies are investigating the possibility that some
environmental factors may predispose a child to develop
the disease. Most leukemias arise from noninherited
mutations (changes) in the genes of growing blood cells.
Because these errors occur randomly and unpredictably,
there is currently no effective way to prevent most types
of leukemia.
To limit the risk of prenatal radiation exposure as a trigger
for leukemia (especially ALL), women who are pregnant
or who suspect that they might be pregnant should
always inform their doctors before undergoing tests or
medical procedures that involve radiation (such as Xrays).
Regular checkups can spot early symptoms of leukemia in
the relatively rare cases where this cancer is linked to an
inherited genetic problem, to prior cancer treatment, or to
use of immunosuppressive drugs for organ transplants.
WHAT ARE THE ALTERNATIVES TO TRANSFER
FACTOR AND IMMUNOTHERAPY
Cancer Treatments
1) Active surveillance (or watchful waiting) - Some
types of cancer grow very slowly and may cause no
problems for many years.
2) Surgery - An operation is done to remove the tumour
3) Radiotherapy - use of high energy x-rays to destroy
cancer cells
4) Chemotherapy - use of anti-cancer (cytotoxic) drugs
to destroy cancer cells.
5) Hormonal Therapy - work by altering the levels of
particular hormones in the body.
6) Other treatments - biological therapies and include
interferon and interleukin.
CANCER RESEARCH - CHEMOTHERAPY AND
REAL THERAPIES


“The medical establishment works closely with the
drug multinationals whose main objective is profits,
and whose worst nightmare would be an epidemic of
good health. Lots of drugs MUST be sold. In order to
achieve this, anything goes: lies, fraud, and
kickbacks. Doctors are the principal salespeople of
the drug companies. They are rewarded with
research grants, gifts, and lavish perks. The principal
buyers are the public - from infants to the elderly who MUST be thoroughly medicated and
vaccinated...at any cost!”
“Why do the authorities forbid alternative medicine?
Because they are serving the industry, and the
industry cannot make money with herbs, vitamins,
and homeopathy. They cannot patent natural
remedies. That is why they push synthetics. They
control medicine, and that is why they are able to tell
medical schools what they can and cannot teach."
Guylaine Lanctot, M.D
Chemotherapy;
Afraid of Their Own Medicine

In one survey, most oncologists specializing in lung
cancer reported that they would not take
chemotherapy if they had the disease. Yet, everyday
these doctors give their patients chemotherapy.
In conversation with an investigative reporter, one
brain cancer specialist admitted that he would never
submit to radiation if he had a brain tumor.
Nevertheless, he continues to send patients for
radiation, because he would be kicked out of the
hospital if he didn't follow the accepted protocol.

Based on information in: Townsend Letter for Doctors and
Patients, Jan 1998; Spectrum, Mar/April 1998
"Drugs do not cure, popular
opinion notwithstanding. Cure
must come from within; or
there is no cure"
- M.L. Tyler M.D
DANGERS OF CHEMOTHERAPY

William Campbell Douglass II, MD - "To understand
the utter hypocrisy of chemotherapy, consider the
following: The McGill Cancer Center in Canada, one
of the largest and most prestigious cancer
treatment centers in the world, did a study of
oncologists to determine how they would respond
to a diagnosis of cancer.
On the confidential questionnaire, 58 out of 64
doctors said that all chemotherapy programs were
unacceptable to them and their family members.
The overriding reason for this decision was that the
drugs are ineffective and have an unacceptable
degree of toxicity. These are the same doctors who
will tell you that their chemotherapy treatments will
shrink your tumor and prolong your life!”
THE POLITICS OF CANCER REVISTED
"The National Cancer Institute and the
American Cancer Society have misled
and confused the public and Congress
by repeated false claims that we are
winning the war against cancer -claims made to create public and
Congressional support for massive
increases in budgetary appropriations."
Dr. Epstein
Gangsters In Medicine



The Journal of the American Medical Association
recently reported that as many as 106,000 deaths
occur annually in US hospitals due to adverse
reactions to prescription drugs that are properly
prescribed by physicians that use them as directed
by the drug companies.
The National Council for Patient Information and
Education reported that an additional 125,000 deaths
occur annually due to adverse reactions to drugs that
the physician never should have prescribed.
The annual death toll from synthetic prescription
drugs, both from the correctly prescribed and the
incorrectly prescribed, amounts to about 231,000
deaths every year.
From the article “Gangsters in Medicine” by Thomas Smith
Classes of Drugs


Chemotherapy drugs for non-metastatic
and metastatic breast cancer fall into
several categories ;
1) Alkylators - affect cancer cells much
like radiation does: by damaging the
proteins that control growth in the genes
of the tumor cell.
2) Antimetabolites - act as false
building blocks in a cancer cell's genes,
causing it to die as it gets ready to divide.
3) Antibiotics - (not to be confused with antibiotics
that fight infection) include potent inhibitors of gene
replication. ("Anti" means "against," and "biotic"
means "growth.")
4) Antimiotic agents - or natural agents rob
cellular genes of the ability to reproduce themselves
during division.
5) Antimicrotubule - or natural agents interfere
with cell structure and cell division.
CHEMOTHERAPY DRUGS





















2'DCF®
2'-deoxycoformycin®
5FU®
Alkeran®
BiCNU®
Caelyx®
Campto®
Cosmegen Lyovac®
DTIC®
Eldisine®
Eloxatin®
Etopophos®
Erwinase®
Fludara®
Gemzar®
Hexalen®
Hycamtin®
Hydrea®
Isovorin®
Lanvis®
Leukeran®






















Leustat®
Matrex®
Mitoxana®
Myleran®
Myocet®
Navelbine®
Nipent®
Oncovin®
Pharmorubicin®
Puri-Nethol®
Sodiofolin®
Taxol®
Taxotere®
Temodal®
Tomudex®
Uftoral®
Uromitexan®
Velbe®
Vepesid®
Xeloda®
Zanosar®
Zavedos®
COMMON FAVOURED DRUGS FOR CHEMO
“Idarubicin”


Idarubicin is chemotherapy that is given as a
treatment for some types of cancer. It is most
commonly used to treat breast cancer, and
some types of leukaemia.
Possible side effects
Each person’s reaction to chemotherapy is unique.
Some people have very few side effects, while
others may experience more. The side effects
described in this information will not affect
everyone who is given idarubicin, and may be
different if you are having more than one
chemotherapy drug. (continue to next slide….)
1)Lowered resistance to infection
2) Bruising or bleeding
3) Anaemia (low number of red blood cells)
4) Nausea (sickness) and vomiting
5) Sore mouth and taste change
6) Tiredness and a general feeling of weakness
7) Hair loss
8) Discoloured urine
-- and several others less common side effects
WHO GETS CANCER ?


1 in 3 people will develop cancer during
their lifetime, but cancer is not common in
children or young people - it mainly occurs
in the later years of life.
Cancers can occur at any age, but the risk
of developing cancer increases with age.
Over 70% of all newly diagnosed cancers
occur in people aged 60 years or more.
WHY DO CANCERS KEEP COMING BACK ?


A cancerous (malignant) tumour consists of
cancer cells which have the ability to spread
beyond the original site. If left untreated
they may invade and destroy surrounding
tissues.
Sometimes cells break away from the
original (primary) cancer and spread to
other organs in the body by travelling in the
bloodstream or lymphatic system. When
these cells reach a new area of the body
they may go on dividing and form a new
tumour, often referred to as a "secondary"
or a "metastasis".
TRANSFER FACTOR STUDY ON 20
CANCER PATIENTS
Rob Robertson, M.D. conducted the following
studies:


Twenty patients, 12 men and 8 women, were selected
for this in vivo study. The average age was 49.3. The
twenty individuals were each level 3 or level 4 cancer
patients. Each patient was basically sent home by his
or her oncologist to die. The average life expectancy
was 3.7 months.
The protocol was to place each patient on 9 capsules
per day of Transfer Factor Plus™. The patients
were given a number of other general
nutrients*. After eight months, 16 of these
individuals were still living and were either in
remission, improving or stabilized.
Overcoming Immunosuppression from
Chemotherapy


Cancer patients who are undergoing chemotherapy
or radiation which greatly weaken the immune
system, can greatly benefit from taking transfer
factor supplementation. Transfer factor
supplementation serves to protect the body from
"opportunistic" infections, which often occur during
these treatments.
Dr Duane Townsend, former director of gynecologic
oncology at LDS Hospital in Salt Lake City, puts all
of his cancer patients on transfer factor treatments
to boost their immune systems’ abilities to respond
to any health challenges.
No Rights for a Child…..
(a true story by parents Raphaele & Michael Horwin)



Over forty years ago, those powerful words were written
and endorsed by many nations throughout the world
including the United States. It is a beautiful declaration but
sadly it is only an illusion. The medical establishment took
every single one of those rights away from our only child
Alexander. Without the right to live, there are no
opportunities for affection, play, or love.
Alexander was two years old when he was diagnosed with
medulloblastoma, the most common pediatric brain tumor.
This cancer is rising in frequency.
After the first round of chemo, Alexander began to change.
Even after two brain operations, Alexander was still a
vibrant, ruddy, strong, energetic child. But as the
chemotherapy repeatedly filled his small body Alexander
began to die inside.
- First the relentless stomach pains and the horrendous
projectile vomiting began. Then his beautiful curly hair fell out.
Next his dark skin tone turned pale as a ghost. He got sick with
fevers and spent weeks in the hospital.
- Then there were the blood transfusions to replace the blood
cells the chemo had killed, the hearing tests to see if the chemo
drug cisplatin had not devastated too much of his hearing, the
nuclear medicine tests to check if his kidneys were not giving up
under the strain of processing so much poison, the liver function
tests to ensure that his liver was not being destroyed, etc.
- During chemotherapy we had to squeeze an antibiotic into his
nose called nystatin several times a day. He hated it and buried
his face in a pillow when he saw it coming with all the strength
his little body could muster. One of us had to pin Alexander
down and keep his head immobile while the other pushed the
syringe into each nostril and injected the solution. We were
also called upon to give him GCSF injections at home.
- Then we found the following statement written by Hyder in our
son’s medical chart. It was dated September 26, 1998:
“Dr. Heideman also called me because he was very concerned
about Mr. and Mrs. Horwin…He was very concerned that the
family would refuse treatment and that a court order would have
to be obtained to treat Alexander.”
- And on October 6, 1998 Hyder continued:
“I think that if Mr. and Mrs. Horwin do not bring Alexander in for
chemotherapy tomorrow, additional steps will be necessary.”
- We went to see an attorney to find out if the oncologists could
take Alexander from us if we decided to stop chemo. Incredibly,
the answer was yes !.
- The oncologists warned us that if we didn’t use chemotherapy
that the tumor would probably return in three months. These
doctors assured us that the chemo they were
administering to our son was the current “state-of-theart.” They told us repeatedly that this was Alexander’s best
choice for a long and healthy life.
- We continued the chemotherapy. As a result of the drugs,
Alexander’s balance was lost, his ability to see deteriorated,
and he lost hearing in one ear. The whole thing was
horrendous.
- After a “clean” MRI on January 4th, Alexander had a spinal
tap. A day later Alexander complained of pain in his head and
back and he began to vomit. We asked for another MRI but
Hyder, the oncolgist, refused because he had done one just a
few days previously. Hyder told us that Alexander’s pain was
just a side effect of the spinal tap. But as each day passed the
pain became worse.
- We brought Alexander into the hospital on January 11th and
Hyder ordered a CAT scan without contrast. We were told that
the scan looked “fine,” although later, we would find out that a
CAT scan especially one taken without contrast is not designed
to reveal the presence of a returning brain tumor.
- Finally, on January 18th, we brought Alexander into the
hospital and demanded a MRI. Hyder refused to order the test.
He explained that it was too late in the day to schedule one.
We had a confrontation. We would not leave until a MRI was
ordered. Finally, Hyder relented. Alexander was wheeled into
the MRI suite.
- An hour later we had the news, Hyder shook his head and
told us that Alexander had over 30 tumors throughout his brain
and spine. “What does that mean?” we asked completely
stunned. Hyder just continued to shake his head.
“What is it?” we asked him. “Leptomeningeal sarcoma. I am
so sorry. There is nothing we can do.” “How is this possible?”
“It happens,” he said. “How often,” we asked. “It happens
sometimes. I’m so sorry.” How long does Alexander have,”
we asked. The surgeon paused. “A few days, perhaps,” he
said.
“The only thing we can do is send you home with hospice care.
I’ll give you a prescription for morphine and decadron,” Hyder
said as he awkwardly patted me on the shoulder. “I think it is
better to keep your son here tonight and you can go home
tomorrow,” he added.
Alexander died on January 31st, 1999 in his mommy’s arms.
Our son was only 2 ½ years old. After Alexander was buried,
Raphaele and I wanted to know what happened. No one ever
told us that the cancer could come back and kill Alexander
while he was on chemotherapy. In fact, Alexander was only
one quarter through a twelve-month chemo protocol
(comprised of induction and maintenance chemotherapy).
The following quotes are taken verbatim from Alexander’s
medical chart. Each entry is written by Hyder.
September 25, 1998

Mr. and Mrs. Horwin and I discussed treatment options
in the office for about two hours…We discussed the
risks of chemotherapy at length including low
hemoglobin, low white blood cells, low platelets,
infection, need for blood transfusion, need for platelet
transfusion, pain, nausea, vomiting, hair loss, skin
injury, heart damage, lung damage, liver damage,
kidney damage, loss of hearing, small stature,
hormonal problems such as low growth hormone or
low thyroid hormone, infertility, second cancer,
intellectual decline, worsening of neurological
symptoms, ineffectiveness, and death. Mr. and Mrs.
Horwin were quite distressed by all the potential side
effects, but I explained that despite all these risks, I
believe the potential benefits of chemotherapy in
prolonging the length of cancer free survival or
possibly cure are greater than the potential risks.
(-- continue to next slide)
October 2, 1998
…without chemotherapy I am quite certain that the
disease will relapse and this could possibly result
in Alexander’s death. PLANS: We will proceed
with chemotherapy like CCG-9921A, as the best
available therapy.
October 3, 1998
I received your voice mail message that you have
decided not to bring Alexander for scheduled
chemotherapy today…Alexander needs
chemotherapy now…We need to get
chemotherapy started if Alexander is to survive
this disease.
(-- continue to next slide)

October 6, 1998
“About 4:30 p.m. on October 5, 1998, Mr. Horwin
telephoned and asked me about a variety of biological
therapies such as “nerve cell growth factor,” “retinoic acid,”
and “tumor necrosis factor”…Mr. Horwin asked to use these
biological therapies for his son before chemotherapy. I
again told him clearly in my professional opinion,
chemotherapy is the next treatment to use because of its
known clinical efficacy. He was distressed by the limitations
of chemotherapy, since treatment is successful in only about
30-40% of children with Alexander’s type of cancer…I
explained that the best opportunity we have to successfully
treat Alexander’s cancer is to use chemotherapy now…I
reiterated that my best professional advice which is to use
chemotherapy now against Alexander’s cancer. I spoke to
Mrs. Horwin and explained what I had explained to her
husband. I told her that my best medical advice is to use
chemotherapy for treatment of Alexander’s cancer. I told
her that without chemotherapy, Alexander may die from
cancer…”
- We began to research “leptomeningeal sarcoma” the cancer
that had grown so rapidly and killed him. One of the abstracts
that came back stunned us.
- It was a study published in 1994 by Dr. Heideman, the
oncologist we had met at St. Judes Children’s Research Hospital.
It discussed the “leptomeningeal progression” of
medulloblastoma in thirteen children Alexander’s age who were
given chemotherapy. It explained how the cancers returned and
spread in eleven of the thirteen children within five months.
- It mentioned that for some of the children the cancers grew in
the spines. Incredibly, this abstract described in detail exactly
what happened to our son. But even more astounding, the
abstract explained that this protocol was terminated due to the
poor performance of the drugs.
- The chemo that they had given these children was identical to
the chemo Hyder had administered to Alexander. The four drugs
were exactly the same - vincristine, cisplatin, cyclophosphamide
and etoposide. The cancer that returned, metastasized and took
Alexander’s life did so in less than five months from the time
when he had his surgeries
- What you are about to read will shock you. It is a story of
oncologists lying to parents and the public about the efficacy of
their therapy. The quotations that follow come from abstracts
and articles printed in their peer reviewed medical journals that
trace the use of these drugs in children starting almost a quarter
of a century ago. It is organized in chronological order.
Incredibly, all these drugs are still being administered to children
in hospitals throughout the country, sometimes without the
parents’ consent.
Alexander was put on protocol CCG 9921 that consists of:
Vincristine
Cyclophosphamide
Cisplatin (very similar to Carboplatin)
Etoposide (also called VP 16)
- 1976 Vincristine causes seizures: In 1976, the oncologists
experiment on children with a drug called vincristine. Twentytwo years later, they would administer the same drug to
Alexander. Here in 1976 they find that the drug causes seizures.
-1978Vincristine does not eliminate cancer: A year later, they tested
vincristine with two other chemotherapy drugs on more
children. The tumors returned in an average of 45 weeks with
the chemo.
-1982Vincristine destroys eyesight: The fact that oncologists were
already warned that vincristine was dangerous to a child’s
eyesight didn’t seem to make an impression. It didn’t for
Alexander’s oncologist in 1998. This article is written about
another child who nearly goes blind from vincristine in 1982.
-1983Cisplatin destroys hearing and leads to neurologic
deterioration: In 1983, the danger of another chemo drug,
cisplatin, is discovered, but only after trying it out on children.
This is another drug the oncologists would inject into Alexander
fifteen years later.
- “Six children received cisplatin for recurrent brain tumor. Five
of the six children had evidence of significant hearing loss after
only one cycle of treatment. Two (children)…developed profound
deterioration in neurologic status within 72 hours after infusion.”
- Granowetter L, Rosenstock JG, Packer RJ: Enhanced cis-platinum
neurotoxity in pediatric patients with brain tumors. J Neurooncol 1983;
1(4):293-7.
- Cyclophosphamide does not affect survival: That same year,
another chemotherapy drug called cyclophosphamide is tried out
on children. It does not effect survival. This is the third of four
drugs they would administer to Alexander many years later. This
article admits that even if a drug is “active” and temporarily
shrinks a tumor, it does not prolong life.
- “A case of fatal myeloencephalopathy (inflammation of the
spinal chord and brain) secondary to accidental intrathecal
administration of vincristine is reported in a 16 year old boy. He
underwent a progressive ascending chemical meningoencephalitis
leading to coma, and died 36 days after the injection. At
autopsy, all regions of the brain that had been in direct contact
with the cerebrospinal fluid were necrotic (dead).”
“Gonadal function was studied in two groups of children
previously treated for medulloblastoma…In group one, but not
in group two, the children also received adjuvant chemotherapy
(BCNU or CCNU plus vincristine in four and procarbazine in
three patients). The nine children in group one showed clinical
and biochemical evidence of gonadal damage… In group two,
each child…(developed) normally…We conclude that
nitrosoureas (chemotherapy) was responsible for the gonadal
damage…”
- Ahmed SR, Shalet SM, Campbell RH, Deakin DP. Primary gonadal
damage following treatment of brain tumors in childhood. J Pediatr
1983 Oct; 103(4): 562-5.
-1984Oncologists may not count dead children in their statistics: The
next year, several chemo drugs including vincristine, and
etoposide, are administered to children in another chemo
experiment. Etoposide is the fourth and last drug in the
chemo cocktail they would administer to Alexander fourteen
years later.
-1985Oncologists admit that chemo is ineffective: A year later,
after trying out all the various chemo drugs on children, a
group of pediatric oncologists admit that the role of
chemotherapy is “unclear, ” that “responses are generally
transient,” and “virtually no cures are reported.” They also
admit again that an “active” drug (a drug that may
temporarily shrink a tumor) has no relationship to a cure.
-1987Oncologists admit that chemo is ineffective and increases the
risk of infection: “The (survival) rate was not improved by
the chemotherapy program. An increased risk of infection
was associated with the chemotherapy.”
- Jenkin RD, Boesel C, Ertel I, Evans A, Hittle R, Ortega J, Sposto R,
Wara W, Wilson C, Anderson J, et al. Brain-stem tumors in
childhood: a prospective randomized trial of irradiation with and
without adjuvant CCNU, VCR, and prednisone. A report of the
Children’s Cancer Study Group. J Neurosurg 1987 Feb; 66(2): 22733.
The fact that chemotherapy actually causes cancer should be of
no surprise to the oncologists. The chemotherapy they gave
Alexander and thousands of other children is listed as “Known
Human Carcinogens” by the National Institute of Health, the
National Cancer Institute and the FDA.
In fact, cyclophosphamide was listed as a “Known Human
Carcinogen” by the First Annual Report on Carcinogens
published by the U.S. Department of Health and Human
Services in 1980. In addition, there are four other
chemotherapy compounds on that list.
Furthermore, the World Health Organization’s International
Agency for Research on Cancer lists ten chemotherapy agents
including cyclophosphamide and all alkylating agents as
“Materials known to be carcinogenic to humans.”
- It is hard to believe that oncologists would be injecting known
human carcinogens into children with cancer. But, that is exactly
what they are doing. They should not feign surprise when the
children begin developing secondary cancers.
- This is what happened to Alexander. His first cancer was
medulloblastoma. After three months of chemotherapy the
cancer returned as 30 separate tumors. At that point the doctors
called it “leptomeningeal sarcoma.”
-1991Chemo leads to destruction of hearing, infertility and secondary
cancers.
- Complications of chemotherapy include,“permanent hearing
impairment secondary to cisplatin, infertility and an increased
risk of second primary neoplasms.”
- Allen JC: Complications of chemotherapy in patients with brain and
spinal cord tumors. Pediatr Neurosurg 1991-92; 17(4): 218-24
-1993The chemo is not the problem, it’s the children who are at
fault: It’s 1993 and the oncologists have a new strategy blame the victim. The drugs are exactly the same. Now, the
problem isn’t that the chemotherapy is worthless. The problem
is the children. They just have a poor prognosis.
“Children younger than 5 years who have PNET have a poor
prognosis.”
- Goldwein JW, Radcliffe J, Packer RJ, Sutton LN, Lange B, Rorke LB,
D’Angio GJ. Results of a pilot study of low-dose craniospinal radiation
therapy plus chemotherapy for children younger than 5 years with
primitive neuroectodermal tumors. Cancer 1993 Apr 15; 71(8): 264752.
- Today, according to the oncologists, children on
chemotherapy have their brain cancers return in an
average of 5-7 months. With chemo, Alexander lived
a little more than five months from when he was
diagnosed and he had all his tumor removed.
- Incredibly, the children operated on 70 and 80 years
ago already beat Alexander in terms of survival, but if
these kids had had the benefit of a modern surgery
they might have lived even longer. Who knows how
long these children would have lived if they had been
given a modern operation?
- This suggested that chemotherapy was shortening
children’s lives, not lengthening them!
-1998But even after these admissions that “virtually no
cures are reported” with chemo in 1985, that
chemo is “controversial” in 1991, “unproven” in
1993, and provides “a poor rate of survival and
high treatment associated morbidity (i.e. side
effects)” in 1997, nothing changes.
Here we are in 1998. The children are still getting
the same drugs. The children die of the disease
or the chemo itself. The conclusion is that the
treatment doesn’t work. How many dead children
did it take to reach that conclusion? What’s worse
is that even with that conclusion, the oncologists
continue to use these drugs on children….